Healthcare
In Japan, we are endeavoring to provide more effec...
In Japan, we are endeavoring to provide more effective and appropriate solutions through combining the extensive pharmaceutical knowledge of our medical representatives (MRs) and the experience of our home healthcare sales representatives in direct contact with patients. This original approach coupled with superior pharmaceuticals/medical devices and high-quality service, has enabled us to attain a major market share in the bone and joint, and respiratory areas in Japan. In recent years, together with initiatives to develop unique products through coordination with the Teijin Group's material businesses, we have been focusing efforts on developing medical equipment for rehabilitation.
In light of concern about aging societies and the increase in lifestyle-related diseases, the Teijin Group is pursuing development/provision of original and innovative medical solutions that enable as many people as possible to lead healthy and enriching lifestyles every day.
Main Products and Services
- Bone and joint diseases
- Treatment for osteoporosis: Bonalon, Onealfa
- Viscosupplement for knee osteoarthritis pain: Synvisc
- Sonic accelerated fracture healing system: SAFHS
- Respiratory diseases
- Expectorant: Mucosolvan
- Inhaled corticosteroid agent for asthma: Alvesco
- Oxygen concentrator for home oxygen therapy (HOT): Hi-SansoTM series
- Respiratory/Cardiovascular and metabolic diseases
- Continuous positive airway pressure (CPAP) unit: SLEEPMATE, AutoSetTM
- Non-invasive positive pressure ventilator: NIP NASAL
- Adaptive servo-ventilator: AutoSetTM CS
- Cardiovascular and metabolic diseases
- Treatment for hyperuricemia and gout: FEBURIC (ULORIC, ADENURIC)
- Treatment for hyperlipidemia: Tricor
- Others
- Intravenous immunoglobulin preparation: Venilon
* Bonalon is the registered trademark of Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USA.
Global Expansion of Treatment for Hyperuricemia an...
Global Expansion of Treatment for Hyperuricemia and Gout
The Teijin Group's self-developed treatment for hyperuricemia and gout* is the first new drug in this area for approximately 40 years worldwide. Positioned as a strategic product, the treatment is expected to become a top-selling drug in the global market. Currently, it is sold in approximately 30 countries worldwide and our future plans are to coordinate with corporations overseas to expand this figure to more than 100 countries.
* Product names: FEBURIC (Japan/Asia), ULORIC (North America), ADENURIC (Europe/Lebanon)
Home Healthcare
Home healthcare is viewed as an aid to an enhanced quality of life for individuals through reducing the burden of hospitalization/hospital visits and enabling treatment to be performed in the home. In Japan, the Teijin Group is a leading company in the home healthcare equipment field, providing HOT equipment, CPAP units for sleep apnea syndrome (SAS) patients and non-invasive positive pressure ventilators. Specialist staff provide a 24-hour/365-day nationwide patient support network with over 90 bases throughout Japan. We are also increasing bases in North America, Europe and Asia and moving ahead actively with global expansion.
Customer reviews
No reviews were found for Healthcare. Be the first to review!